Mini review · 13 Apr 2026
Conference abstractPublished 30 Aug 2016
The association of FGF-23 levels with insulin resistance and carotid intima media thickness in obese adolescents
Medical Center- Inonu University, Turkey
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Fibroblast growth factor (FGF-23) is a hormonal regulator of circulating phosphate and vitamin D levels, and it may also act as a âÂ?Â?hormone-likeâÂ?Â? factor involved in the glucose and fat metabolism. Some studies have showen that FGF-23 has a potential role in the development of insulin resistance and vascular dysfunction and adverse thickening of the vascular wall, however ,it remains controversial. It was to investigate the possible correlations between serum FGF-23 levels and body compositions, insulin resistance and carotid intima media thickness (cIMT) in obese adolescents. The study included 46 obese adolescents (22 boys and 24 girls) and 46 non-obese healthy adolescents (18 girls and 28 boys). The exclusion criteria were presence of disorders of calcium phosphor metabolism or any chronic diseases. HOMA-IR values were calculated by using fasting insulin and blood glucose values in all patients and controls. Plasma FGF-23 level was measured using ELISA, cIMT was evaluated ultrasonographically. HOMA-IR , fasting insulin levels were significantly higher in obese group than controls, but FGF-23 and klotho levels were significantly lower in obese group (FGF-23: 310Ã?±97 pg/ml, Klotho: 33.45Ã?±10.9 pg/ml) when compared with controls ( FGF-23: 515.71Ã?±142 pg/ml, Klotho: 56.17Ã?±22 pg/ml). In this group, FGF-23 and Klotho were negatively correlated fasting insulin and HOMA-IR. cIMT values were incresead in obese group (0.56 mm) than those of controls (0.41 mm) and positively correlated with BMI, fasting insulin and HOMA-IR level, but not FGF-23 levels. These findings suggest that incresed insulin level may cause of lower FGF-23 and klotho levels in obese patients. Increased cMIT is more likely related to insulin resistance, but not FGF-23 in obese patients.
Subjects
Obesity & Weight ManagementAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Obesity & Weight Loss Therapy.
Research article · 27 Feb 2026
Modulation of Postprandial GLP-1 Secretion and Glycemic Responses by a Food-Grade GLP-1 Formula in Human Subjects
Short communication · 9 Feb 2026
Intensive Blood Pressure Lowering Target Guided by Home Blood Pressure Monitoring for Hypertensive Patients with Type 2 Diabetes, Which is Better or Not
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Obesity & Weight Loss Therapy
- SubjectObesity & Weight Management
- BylineArticles whose byline prints “Aysehan Akinci”